nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—CYP2A6—Pilocarpine—glaucoma	0.13	0.194	CbGbCtD
Dapagliflozin—CYP1A1—Clonidine—glaucoma	0.0541	0.081	CbGbCtD
Dapagliflozin—CYP2D6—Carteolol—glaucoma	0.0538	0.0805	CbGbCtD
Dapagliflozin—CYP1A2—Betaxolol—glaucoma	0.0441	0.066	CbGbCtD
Dapagliflozin—CYP2D6—Betaxolol—glaucoma	0.0363	0.0544	CbGbCtD
Dapagliflozin—CYP2C9—Diclofenamide—glaucoma	0.035	0.0524	CbGbCtD
Dapagliflozin—CYP2C9—Dorzolamide—glaucoma	0.0338	0.0506	CbGbCtD
Dapagliflozin—CYP2C9—Methazolamide—glaucoma	0.0301	0.0451	CbGbCtD
Dapagliflozin—CYP2D6—Methazolamide—glaucoma	0.0275	0.0412	CbGbCtD
Dapagliflozin—CYP3A4—Pilocarpine—glaucoma	0.0259	0.0388	CbGbCtD
Dapagliflozin—ABCB1—Timolol—glaucoma	0.0249	0.0372	CbGbCtD
Dapagliflozin—CYP1A2—Clonidine—glaucoma	0.0242	0.0362	CbGbCtD
Dapagliflozin—CYP2D6—Timolol—glaucoma	0.0234	0.0351	CbGbCtD
Dapagliflozin—ABCB1—Clonidine—glaucoma	0.0211	0.0316	CbGbCtD
Dapagliflozin—CYP3A4—Brinzolamide—glaucoma	0.0203	0.0305	CbGbCtD
Dapagliflozin—CYP2D6—Clonidine—glaucoma	0.0199	0.0298	CbGbCtD
Dapagliflozin—CYP3A4—Dorzolamide—glaucoma	0.0196	0.0294	CbGbCtD
Dapagliflozin—CYP3A4—Methazolamide—glaucoma	0.0175	0.0262	CbGbCtD
Dapagliflozin—CYP3A4—Acetazolamide—glaucoma	0.014	0.021	CbGbCtD
Dapagliflozin—CYP3A4—Clonidine—glaucoma	0.0127	0.019	CbGbCtD
Dapagliflozin—Infestation—Travoprost—glaucoma	0.000759	0.00374	CcSEcCtD
Dapagliflozin—Hypotension—Carbachol—glaucoma	0.000759	0.00374	CcSEcCtD
Dapagliflozin—Dysuria—Pilocarpine—glaucoma	0.000755	0.00372	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Dorzolamide—glaucoma	0.000751	0.0037	CcSEcCtD
Dapagliflozin—Infestation NOS—Brinzolamide—glaucoma	0.000749	0.00369	CcSEcCtD
Dapagliflozin—Infestation—Brinzolamide—glaucoma	0.000749	0.00369	CcSEcCtD
Dapagliflozin—Hypotension—Levobunolol—glaucoma	0.000747	0.00368	CcSEcCtD
Dapagliflozin—Myocardial infarction—Dorzolamide—glaucoma	0.000747	0.00368	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Betaxolol—glaucoma	0.000747	0.00368	CcSEcCtD
Dapagliflozin—Pain in extremity—Clonidine—glaucoma	0.000746	0.00368	CcSEcCtD
Dapagliflozin—Pollakiuria—Pilocarpine—glaucoma	0.000746	0.00368	CcSEcCtD
Dapagliflozin—Oedema—Latanoprost—glaucoma	0.000742	0.00366	CcSEcCtD
Dapagliflozin—Urinary tract infection—Dorzolamide—glaucoma	0.000741	0.00365	CcSEcCtD
Dapagliflozin—Urinary tract infection—Travoprost—glaucoma	0.000738	0.00364	CcSEcCtD
Dapagliflozin—Skin disorder—Latanoprost—glaucoma	0.00072	0.00355	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Diclofenamide—glaucoma	0.000718	0.00354	CcSEcCtD
Dapagliflozin—Constipation—Diclofenamide—glaucoma	0.000711	0.00351	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Pilocarpine—glaucoma	0.00071	0.0035	CcSEcCtD
Dapagliflozin—Myocardial infarction—Pilocarpine—glaucoma	0.000706	0.00348	CcSEcCtD
Dapagliflozin—Urinary tract infection—Pilocarpine—glaucoma	0.0007	0.00345	CcSEcCtD
Dapagliflozin—Blood urea increased—Timolol—glaucoma	0.00069	0.0034	CcSEcCtD
Dapagliflozin—Thirst—Betaxolol—glaucoma	0.000683	0.00336	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Clonidine—glaucoma	0.000682	0.00336	CcSEcCtD
Dapagliflozin—Hypersensitivity—Metipranolol—glaucoma	0.000673	0.00332	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Travoprost—glaucoma	0.000673	0.00332	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Travoprost—glaucoma	0.000669	0.0033	CcSEcCtD
Dapagliflozin—Urethral disorder—Travoprost—glaucoma	0.000668	0.00329	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Clonidine—glaucoma	0.000667	0.00329	CcSEcCtD
Dapagliflozin—Hypoglycaemia—Betaxolol—glaucoma	0.000666	0.00328	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Brinzolamide—glaucoma	0.000664	0.00327	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Methazolamide—glaucoma	0.000661	0.00326	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Brinzolamide—glaucoma	0.000661	0.00326	CcSEcCtD
Dapagliflozin—Urethral disorder—Brinzolamide—glaucoma	0.000659	0.00325	CcSEcCtD
Dapagliflozin—Body temperature increased—Diclofenamide—glaucoma	0.000658	0.00324	CcSEcCtD
Dapagliflozin—Body temperature increased—Carbachol—glaucoma	0.000642	0.00316	CcSEcCtD
Dapagliflozin—Urticaria—Levobunolol—glaucoma	0.000635	0.00313	CcSEcCtD
Dapagliflozin—Hypersensitivity—Carteolol—glaucoma	0.000623	0.00307	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000614	0.00303	CcSEcCtD
Dapagliflozin—Discomfort—Apraclonidine—glaucoma	0.000611	0.00301	CcSEcCtD
Dapagliflozin—Urticaria—Methazolamide—glaucoma	0.000609	0.003	CcSEcCtD
Dapagliflozin—Hypertension—Bimatoprost—glaucoma	0.000608	0.003	CcSEcCtD
Dapagliflozin—Body temperature increased—Methazolamide—glaucoma	0.000606	0.00299	CcSEcCtD
Dapagliflozin—Dizziness—Metipranolol—glaucoma	0.000604	0.00298	CcSEcCtD
Dapagliflozin—Dysuria—Clonidine—glaucoma	0.000603	0.00297	CcSEcCtD
Dapagliflozin—Pollakiuria—Clonidine—glaucoma	0.000596	0.00294	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000595	0.00294	CcSEcCtD
Dapagliflozin—Oedema—Apraclonidine—glaucoma	0.000593	0.00292	CcSEcCtD
Dapagliflozin—Hypersensitivity—Levobunolol—glaucoma	0.000589	0.0029	CcSEcCtD
Dapagliflozin—Infection—Apraclonidine—glaucoma	0.000589	0.0029	CcSEcCtD
Dapagliflozin—Malnutrition—Brinzolamide—glaucoma	0.000585	0.00289	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Betaxolol—glaucoma	0.000581	0.00286	CcSEcCtD
Dapagliflozin—Back pain—Dorzolamide—glaucoma	0.000576	0.00284	CcSEcCtD
Dapagliflozin—Rash—Metipranolol—glaucoma	0.000576	0.00284	CcSEcCtD
Dapagliflozin—Skin disorder—Apraclonidine—glaucoma	0.000576	0.00284	CcSEcCtD
Dapagliflozin—Dermatitis—Metipranolol—glaucoma	0.000575	0.00284	CcSEcCtD
Dapagliflozin—Back pain—Travoprost—glaucoma	0.000574	0.00283	CcSEcCtD
Dapagliflozin—Headache—Metipranolol—glaucoma	0.000572	0.00282	CcSEcCtD
Dapagliflozin—Infection—Bimatoprost—glaucoma	0.000571	0.00281	CcSEcCtD
Dapagliflozin—Back pain—Brinzolamide—glaucoma	0.000566	0.00279	CcSEcCtD
Dapagliflozin—Influenza—Betaxolol—glaucoma	0.000561	0.00277	CcSEcCtD
Dapagliflozin—Dizziness—Carteolol—glaucoma	0.00056	0.00276	CcSEcCtD
Dapagliflozin—Urinary tract infection—Clonidine—glaucoma	0.000559	0.00276	CcSEcCtD
Dapagliflozin—Skin disorder—Bimatoprost—glaucoma	0.000558	0.00275	CcSEcCtD
Dapagliflozin—Dizziness—Diclofenamide—glaucoma	0.00055	0.00271	CcSEcCtD
Dapagliflozin—Angina pectoris—Betaxolol—glaucoma	0.000547	0.0027	CcSEcCtD
Dapagliflozin—Discomfort—Acetazolamide—glaucoma	0.000547	0.00269	CcSEcCtD
Dapagliflozin—Back pain—Pilocarpine—glaucoma	0.000544	0.00268	CcSEcCtD
Dapagliflozin—Angioedema—Dorzolamide—glaucoma	0.000544	0.00268	CcSEcCtD
Dapagliflozin—Hypoglycaemia—Timolol—glaucoma	0.000544	0.00268	CcSEcCtD
Dapagliflozin—Nausea—Metipranolol—glaucoma	0.000543	0.00267	CcSEcCtD
Dapagliflozin—Cerebrovascular accident—Timolol—glaucoma	0.000542	0.00267	CcSEcCtD
Dapagliflozin—Hypertension—Brimonidine—glaucoma	0.000538	0.00265	CcSEcCtD
Dapagliflozin—Dizziness—Carbachol—glaucoma	0.000537	0.00265	CcSEcCtD
Dapagliflozin—Pain in extremity—Timolol—glaucoma	0.000531	0.00262	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Acetazolamide—glaucoma	0.00053	0.00261	CcSEcCtD
Dapagliflozin—Headache—Carteolol—glaucoma	0.00053	0.00261	CcSEcCtD
Dapagliflozin—Dizziness—Levobunolol—glaucoma	0.000529	0.00261	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000527	0.0026	CcSEcCtD
Dapagliflozin—Dysuria—Betaxolol—glaucoma	0.000525	0.00259	CcSEcCtD
Dapagliflozin—Rash—Diclofenamide—glaucoma	0.000525	0.00259	CcSEcCtD
Dapagliflozin—Discomfort—Brimonidine—glaucoma	0.000525	0.00259	CcSEcCtD
Dapagliflozin—Headache—Diclofenamide—glaucoma	0.000521	0.00257	CcSEcCtD
Dapagliflozin—Hypertension—Dorzolamide—glaucoma	0.000514	0.00253	CcSEcCtD
Dapagliflozin—Rash—Carbachol—glaucoma	0.000512	0.00252	CcSEcCtD
Dapagliflozin—Hypertension—Travoprost—glaucoma	0.000512	0.00252	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000512	0.00252	CcSEcCtD
Dapagliflozin—Dermatitis—Carbachol—glaucoma	0.000512	0.00252	CcSEcCtD
Dapagliflozin—Oedema—Brimonidine—glaucoma	0.000509	0.00251	CcSEcCtD
Dapagliflozin—Headache—Carbachol—glaucoma	0.000509	0.00251	CcSEcCtD
Dapagliflozin—Constipation—Apraclonidine—glaucoma	0.000507	0.0025	CcSEcCtD
Dapagliflozin—Infection—Brimonidine—glaucoma	0.000506	0.00249	CcSEcCtD
Dapagliflozin—Hypertension—Brinzolamide—glaucoma	0.000505	0.00249	CcSEcCtD
Dapagliflozin—Nausea—Carteolol—glaucoma	0.000503	0.00248	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000501	0.00247	CcSEcCtD
Dapagliflozin—Headache—Levobunolol—glaucoma	0.000501	0.00247	CcSEcCtD
Dapagliflozin—Discomfort—Dorzolamide—glaucoma	0.000501	0.00247	CcSEcCtD
Dapagliflozin—Infestation NOS—Betaxolol—glaucoma	0.000501	0.00247	CcSEcCtD
Dapagliflozin—Infestation—Betaxolol—glaucoma	0.000501	0.00247	CcSEcCtD
Dapagliflozin—Discomfort—Travoprost—glaucoma	0.000499	0.00246	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000496	0.00245	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000495	0.00244	CcSEcCtD
Dapagliflozin—Skin disorder—Brimonidine—glaucoma	0.000494	0.00244	CcSEcCtD
Dapagliflozin—Nausea—Diclofenamide—glaucoma	0.000494	0.00244	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Betaxolol—glaucoma	0.000494	0.00243	CcSEcCtD
Dapagliflozin—Discomfort—Brinzolamide—glaucoma	0.000492	0.00243	CcSEcCtD
Dapagliflozin—Myocardial infarction—Betaxolol—glaucoma	0.000491	0.00242	CcSEcCtD
Dapagliflozin—Dizziness—Latanoprost—glaucoma	0.00049	0.00242	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Dorzolamide—glaucoma	0.000486	0.0024	CcSEcCtD
Dapagliflozin—Oedema—Dorzolamide—glaucoma	0.000486	0.0024	CcSEcCtD
Dapagliflozin—Hypertension—Pilocarpine—glaucoma	0.000486	0.00239	CcSEcCtD
Dapagliflozin—Oedema—Travoprost—glaucoma	0.000484	0.00239	CcSEcCtD
Dapagliflozin—Rash—Methazolamide—glaucoma	0.000483	0.00238	CcSEcCtD
Dapagliflozin—Dermatitis—Methazolamide—glaucoma	0.000483	0.00238	CcSEcCtD
Dapagliflozin—Nausea—Carbachol—glaucoma	0.000482	0.00238	CcSEcCtD
Dapagliflozin—Infection—Travoprost—glaucoma	0.000481	0.00237	CcSEcCtD
Dapagliflozin—Headache—Methazolamide—glaucoma	0.00048	0.00237	CcSEcCtD
Dapagliflozin—Hypotension—Brimonidine—glaucoma	0.000476	0.00234	CcSEcCtD
Dapagliflozin—Nausea—Levobunolol—glaucoma	0.000475	0.00234	CcSEcCtD
Dapagliflozin—Infection—Brinzolamide—glaucoma	0.000475	0.00234	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Timolol—glaucoma	0.000475	0.00234	CcSEcCtD
Dapagliflozin—Discomfort—Pilocarpine—glaucoma	0.000473	0.00233	CcSEcCtD
Dapagliflozin—Skin disorder—Travoprost—glaucoma	0.00047	0.00232	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Dorzolamide—glaucoma	0.00047	0.00232	CcSEcCtD
Dapagliflozin—Rash—Latanoprost—glaucoma	0.000468	0.0023	CcSEcCtD
Dapagliflozin—Dermatitis—Latanoprost—glaucoma	0.000467	0.0023	CcSEcCtD
Dapagliflozin—Headache—Latanoprost—glaucoma	0.000465	0.00229	CcSEcCtD
Dapagliflozin—Skin disorder—Brinzolamide—glaucoma	0.000464	0.00229	CcSEcCtD
Dapagliflozin—Oedema—Pilocarpine—glaucoma	0.000459	0.00226	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000458	0.00226	CcSEcCtD
Dapagliflozin—Infection—Pilocarpine—glaucoma	0.000456	0.00225	CcSEcCtD
Dapagliflozin—Nausea—Methazolamide—glaucoma	0.000455	0.00224	CcSEcCtD
Dapagliflozin—Hypotension—Dorzolamide—glaucoma	0.000454	0.00224	CcSEcCtD
Dapagliflozin—Hypotension—Travoprost—glaucoma	0.000452	0.00223	CcSEcCtD
Dapagliflozin—Angina pectoris—Timolol—glaucoma	0.000447	0.0022	CcSEcCtD
Dapagliflozin—Hypotension—Brinzolamide—glaucoma	0.000447	0.0022	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Pilocarpine—glaucoma	0.000444	0.00219	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Brimonidine—glaucoma	0.000439	0.00217	CcSEcCtD
Dapagliflozin—Hypersensitivity—Apraclonidine—glaucoma	0.000437	0.00215	CcSEcCtD
Dapagliflozin—Hypotension—Pilocarpine—glaucoma	0.000429	0.00212	CcSEcCtD
Dapagliflozin—Dysuria—Timolol—glaucoma	0.000429	0.00211	CcSEcCtD
Dapagliflozin—Urticaria—Acetazolamide—glaucoma	0.000421	0.00208	CcSEcCtD
Dapagliflozin—Body temperature increased—Acetazolamide—glaucoma	0.000419	0.00207	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Travoprost—glaucoma	0.000418	0.00206	CcSEcCtD
Dapagliflozin—Constipation—Travoprost—glaucoma	0.000414	0.00204	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000413	0.00203	CcSEcCtD
Dapagliflozin—Angioedema—Clonidine—glaucoma	0.000411	0.00202	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000397	0.00195	CcSEcCtD
Dapagliflozin—Constipation—Pilocarpine—glaucoma	0.000393	0.00194	CcSEcCtD
Dapagliflozin—Dizziness—Apraclonidine—glaucoma	0.000392	0.00193	CcSEcCtD
Dapagliflozin—Malnutrition—Betaxolol—glaucoma	0.000391	0.00193	CcSEcCtD
Dapagliflozin—Urticaria—Dorzolamide—glaucoma	0.000386	0.0019	CcSEcCtD
Dapagliflozin—Body temperature increased—Dorzolamide—glaucoma	0.000384	0.00189	CcSEcCtD
Dapagliflozin—Dizziness—Bimatoprost—glaucoma	0.00038	0.00187	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00038	0.00187	CcSEcCtD
Dapagliflozin—Urticaria—Brinzolamide—glaucoma	0.00038	0.00187	CcSEcCtD
Dapagliflozin—Discomfort—Clonidine—glaucoma	0.000378	0.00186	CcSEcCtD
Dapagliflozin—Hypersensitivity—Brimonidine—glaucoma	0.000375	0.00185	CcSEcCtD
Dapagliflozin—Dermatitis—Apraclonidine—glaucoma	0.000373	0.00184	CcSEcCtD
Dapagliflozin—Headache—Apraclonidine—glaucoma	0.000371	0.00183	CcSEcCtD
Dapagliflozin—Oedema—Clonidine—glaucoma	0.000367	0.00181	CcSEcCtD
Dapagliflozin—Infection—Clonidine—glaucoma	0.000364	0.0018	CcSEcCtD
Dapagliflozin—Body temperature increased—Pilocarpine—glaucoma	0.000363	0.00179	CcSEcCtD
Dapagliflozin—Rash—Bimatoprost—glaucoma	0.000362	0.00179	CcSEcCtD
Dapagliflozin—Dermatitis—Bimatoprost—glaucoma	0.000362	0.00178	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Timolol—glaucoma	0.000361	0.00178	CcSEcCtD
Dapagliflozin—Headache—Bimatoprost—glaucoma	0.00036	0.00177	CcSEcCtD
Dapagliflozin—Hypersensitivity—Dorzolamide—glaucoma	0.000358	0.00177	CcSEcCtD
Dapagliflozin—Hypersensitivity—Travoprost—glaucoma	0.000357	0.00176	CcSEcCtD
Dapagliflozin—Skin disorder—Clonidine—glaucoma	0.000356	0.00176	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Clonidine—glaucoma	0.000355	0.00175	CcSEcCtD
Dapagliflozin—Nausea—Apraclonidine—glaucoma	0.000352	0.00174	CcSEcCtD
Dapagliflozin—Hypersensitivity—Brinzolamide—glaucoma	0.000352	0.00174	CcSEcCtD
Dapagliflozin—Dizziness—Acetazolamide—glaucoma	0.000351	0.00173	CcSEcCtD
Dapagliflozin—Hypotension—Clonidine—glaucoma	0.000343	0.00169	CcSEcCtD
Dapagliflozin—Nausea—Bimatoprost—glaucoma	0.000341	0.00168	CcSEcCtD
Dapagliflozin—Hypersensitivity—Pilocarpine—glaucoma	0.000338	0.00167	CcSEcCtD
Dapagliflozin—Dizziness—Brimonidine—glaucoma	0.000337	0.00166	CcSEcCtD
Dapagliflozin—Headache—Acetazolamide—glaucoma	0.000332	0.00164	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000331	0.00163	CcSEcCtD
Dapagliflozin—Discomfort—Betaxolol—glaucoma	0.000329	0.00162	CcSEcCtD
Dapagliflozin—Dizziness—Dorzolamide—glaucoma	0.000321	0.00158	CcSEcCtD
Dapagliflozin—Rash—Brimonidine—glaucoma	0.000321	0.00158	CcSEcCtD
Dapagliflozin—Dermatitis—Brimonidine—glaucoma	0.000321	0.00158	CcSEcCtD
Dapagliflozin—Dizziness—Travoprost—glaucoma	0.00032	0.00158	CcSEcCtD
Dapagliflozin—Malnutrition—Timolol—glaucoma	0.00032	0.00158	CcSEcCtD
Dapagliflozin—Oedema—Betaxolol—glaucoma	0.000319	0.00157	CcSEcCtD
Dapagliflozin—Headache—Brimonidine—glaucoma	0.000319	0.00157	CcSEcCtD
Dapagliflozin—Infection—Betaxolol—glaucoma	0.000317	0.00156	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Clonidine—glaucoma	0.000317	0.00156	CcSEcCtD
Dapagliflozin—Dizziness—Brinzolamide—glaucoma	0.000316	0.00156	CcSEcCtD
Dapagliflozin—Nausea—Acetazolamide—glaucoma	0.000315	0.00155	CcSEcCtD
Dapagliflozin—Constipation—Clonidine—glaucoma	0.000314	0.00155	CcSEcCtD
Dapagliflozin—Skin disorder—Betaxolol—glaucoma	0.00031	0.00153	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Betaxolol—glaucoma	0.000309	0.00152	CcSEcCtD
Dapagliflozin—Rash—Dorzolamide—glaucoma	0.000306	0.00151	CcSEcCtD
Dapagliflozin—Dermatitis—Dorzolamide—glaucoma	0.000306	0.00151	CcSEcCtD
Dapagliflozin—Rash—Travoprost—glaucoma	0.000305	0.0015	CcSEcCtD
Dapagliflozin—Dermatitis—Travoprost—glaucoma	0.000305	0.0015	CcSEcCtD
Dapagliflozin—Headache—Dorzolamide—glaucoma	0.000304	0.0015	CcSEcCtD
Dapagliflozin—Dizziness—Pilocarpine—glaucoma	0.000304	0.0015	CcSEcCtD
Dapagliflozin—Headache—Travoprost—glaucoma	0.000303	0.00149	CcSEcCtD
Dapagliflozin—Nausea—Brimonidine—glaucoma	0.000302	0.00149	CcSEcCtD
Dapagliflozin—Rash—Brinzolamide—glaucoma	0.000301	0.00149	CcSEcCtD
Dapagliflozin—Dermatitis—Brinzolamide—glaucoma	0.000301	0.00148	CcSEcCtD
Dapagliflozin—Headache—Brinzolamide—glaucoma	0.000299	0.00148	CcSEcCtD
Dapagliflozin—Hypotension—Betaxolol—glaucoma	0.000298	0.00147	CcSEcCtD
Dapagliflozin—Angioedema—Timolol—glaucoma	0.000292	0.00144	CcSEcCtD
Dapagliflozin—Urticaria—Clonidine—glaucoma	0.000291	0.00144	CcSEcCtD
Dapagliflozin—Body temperature increased—Clonidine—glaucoma	0.00029	0.00143	CcSEcCtD
Dapagliflozin—Rash—Pilocarpine—glaucoma	0.00029	0.00143	CcSEcCtD
Dapagliflozin—Dermatitis—Pilocarpine—glaucoma	0.000289	0.00143	CcSEcCtD
Dapagliflozin—Nausea—Dorzolamide—glaucoma	0.000289	0.00142	CcSEcCtD
Dapagliflozin—Headache—Pilocarpine—glaucoma	0.000288	0.00142	CcSEcCtD
Dapagliflozin—Nausea—Travoprost—glaucoma	0.000287	0.00142	CcSEcCtD
Dapagliflozin—Nausea—Brinzolamide—glaucoma	0.000284	0.0014	CcSEcCtD
Dapagliflozin—Hypertension—Timolol—glaucoma	0.000276	0.00136	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Betaxolol—glaucoma	0.000276	0.00136	CcSEcCtD
Dapagliflozin—Constipation—Betaxolol—glaucoma	0.000273	0.00135	CcSEcCtD
Dapagliflozin—Nausea—Pilocarpine—glaucoma	0.000273	0.00134	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00027	0.00133	CcSEcCtD
Dapagliflozin—Hypersensitivity—Clonidine—glaucoma	0.00027	0.00133	CcSEcCtD
Dapagliflozin—Discomfort—Timolol—glaucoma	0.000269	0.00133	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Timolol—glaucoma	0.000261	0.00129	CcSEcCtD
Dapagliflozin—Oedema—Timolol—glaucoma	0.000261	0.00129	CcSEcCtD
Dapagliflozin—Infection—Timolol—glaucoma	0.000259	0.00128	CcSEcCtD
Dapagliflozin—Urticaria—Betaxolol—glaucoma	0.000254	0.00125	CcSEcCtD
Dapagliflozin—Skin disorder—Timolol—glaucoma	0.000253	0.00125	CcSEcCtD
Dapagliflozin—Body temperature increased—Betaxolol—glaucoma	0.000252	0.00124	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Timolol—glaucoma	0.000252	0.00124	CcSEcCtD
Dapagliflozin—Hypotension—Timolol—glaucoma	0.000244	0.0012	CcSEcCtD
Dapagliflozin—Dizziness—Clonidine—glaucoma	0.000243	0.0012	CcSEcCtD
Dapagliflozin—Hypersensitivity—Betaxolol—glaucoma	0.000235	0.00116	CcSEcCtD
Dapagliflozin—Rash—Clonidine—glaucoma	0.000231	0.00114	CcSEcCtD
Dapagliflozin—Dermatitis—Clonidine—glaucoma	0.000231	0.00114	CcSEcCtD
Dapagliflozin—Headache—Clonidine—glaucoma	0.00023	0.00113	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Timolol—glaucoma	0.000225	0.00111	CcSEcCtD
Dapagliflozin—Nausea—Clonidine—glaucoma	0.000218	0.00107	CcSEcCtD
Dapagliflozin—Dizziness—Betaxolol—glaucoma	0.000211	0.00104	CcSEcCtD
Dapagliflozin—Urticaria—Timolol—glaucoma	0.000207	0.00102	CcSEcCtD
Dapagliflozin—Body temperature increased—Timolol—glaucoma	0.000206	0.00102	CcSEcCtD
Dapagliflozin—Rash—Betaxolol—glaucoma	0.000201	0.000992	CcSEcCtD
Dapagliflozin—Dermatitis—Betaxolol—glaucoma	0.000201	0.000991	CcSEcCtD
Dapagliflozin—Headache—Betaxolol—glaucoma	0.0002	0.000986	CcSEcCtD
Dapagliflozin—Hypersensitivity—Timolol—glaucoma	0.000192	0.000947	CcSEcCtD
Dapagliflozin—Nausea—Betaxolol—glaucoma	0.00019	0.000935	CcSEcCtD
Dapagliflozin—Dizziness—Timolol—glaucoma	0.000172	0.00085	CcSEcCtD
Dapagliflozin—Rash—Timolol—glaucoma	0.000164	0.000811	CcSEcCtD
Dapagliflozin—Dermatitis—Timolol—glaucoma	0.000164	0.00081	CcSEcCtD
Dapagliflozin—Headache—Timolol—glaucoma	0.000163	0.000806	CcSEcCtD
Dapagliflozin—Nausea—Timolol—glaucoma	0.000155	0.000764	CcSEcCtD
Dapagliflozin—SLC5A4—Disease—BAD—glaucoma	9.08e-05	0.000703	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—CYP1B1—glaucoma	9.03e-05	0.000699	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metapathway biotransformation—CYP1B1—glaucoma	8.9e-05	0.000689	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—MTHFR—glaucoma	8.77e-05	0.000679	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	8.7e-05	0.000674	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—GSTT1—glaucoma	8.53e-05	0.00066	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—GSTT1—glaucoma	8.45e-05	0.000654	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.43e-05	0.000653	CbGpPWpGaD
Dapagliflozin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	8.4e-05	0.000651	CbGpPWpGaD
Dapagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.36e-05	0.000647	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CA1—glaucoma	8.31e-05	0.000643	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—APOE—glaucoma	8.16e-05	0.000632	CbGpPWpGaD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	8.15e-05	0.000631	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	8.13e-05	0.00063	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—CAV1—glaucoma	8.09e-05	0.000626	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CTSA—glaucoma	8.05e-05	0.000623	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NARFL—glaucoma	7.94e-05	0.000615	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CA5A—glaucoma	7.94e-05	0.000615	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—MTHFR—glaucoma	7.93e-05	0.000614	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—MTHFR—glaucoma	7.93e-05	0.000614	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	7.89e-05	0.000611	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	7.89e-05	0.000611	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase II conjugation—GSTM1—glaucoma	7.86e-05	0.000609	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.78e-05	0.000602	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CA2—glaucoma	7.6e-05	0.000588	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GSTM1—glaucoma	7.52e-05	0.000582	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GSTM1—glaucoma	7.52e-05	0.000582	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	7.45e-05	0.000577	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—APOE—glaucoma	7.39e-05	0.000572	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—APOE—glaucoma	7.39e-05	0.000572	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CAV1—glaucoma	7.32e-05	0.000567	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CAV1—glaucoma	7.32e-05	0.000567	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—NOS3—glaucoma	7.3e-05	0.000565	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ABCA1—glaucoma	7.26e-05	0.000562	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CYP1B1—glaucoma	7.26e-05	0.000562	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—GSTT1—glaucoma	7.22e-05	0.000559	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—GSTM1—glaucoma	7.22e-05	0.000559	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	7.12e-05	0.000551	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	7.06e-05	0.000546	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	7.06e-05	0.000546	CbGpPWpGaD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	6.97e-05	0.00054	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—BAD—glaucoma	6.88e-05	0.000533	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—BAD—glaucoma	6.88e-05	0.000533	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—CYP1B1—glaucoma	6.79e-05	0.000526	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CA1—glaucoma	6.75e-05	0.000523	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—CYP1B1—glaucoma	6.73e-05	0.000521	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	6.7e-05	0.000519	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PTGS2—glaucoma	6.68e-05	0.000517	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—MTHFR—glaucoma	6.64e-05	0.000514	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—MTHFR—glaucoma	6.64e-05	0.000514	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	6.64e-05	0.000514	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CTSA—glaucoma	6.54e-05	0.000506	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CA5A—glaucoma	6.34e-05	0.000491	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NARFL—glaucoma	6.34e-05	0.000491	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CDKN1B—glaucoma	6.32e-05	0.00049	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.29e-05	0.000487	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—APOE—glaucoma	6.19e-05	0.000479	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—APOE—glaucoma	6.19e-05	0.000479	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CA2—glaucoma	6.17e-05	0.000478	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—CAV1—glaucoma	6.13e-05	0.000474	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—CAV1—glaucoma	6.13e-05	0.000474	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—NOS3—glaucoma	6.11e-05	0.000473	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	6.06e-05	0.000469	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.03e-05	0.000467	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.03e-05	0.000467	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CA5A—glaucoma	5.98e-05	0.000463	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NARFL—glaucoma	5.98e-05	0.000463	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CA5A—glaucoma	5.92e-05	0.000459	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NARFL—glaucoma	5.92e-05	0.000459	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	5.87e-05	0.000454	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GSTM1—glaucoma	5.8e-05	0.000449	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—CYP1B1—glaucoma	5.75e-05	0.000446	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	5.68e-05	0.000439	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTGS2—glaucoma	5.59e-05	0.000433	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	5.59e-05	0.000433	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.57e-05	0.000432	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	5.55e-05	0.00043	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—NOS3—glaucoma	5.53e-05	0.000428	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—NOS3—glaucoma	5.53e-05	0.000428	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	5.51e-05	0.000426	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—GSTM1—glaucoma	5.43e-05	0.00042	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—GSTM1—glaucoma	5.38e-05	0.000417	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.38e-05	0.000416	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	5.36e-05	0.000415	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—TXN—glaucoma	5.35e-05	0.000414	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	5.31e-05	0.000411	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CA1—glaucoma	5.2e-05	0.000403	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.19e-05	0.000402	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—MTHFR—glaucoma	5.13e-05	0.000397	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NARFL—glaucoma	5.06e-05	0.000392	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CA5A—glaucoma	5.06e-05	0.000392	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PTGS2—glaucoma	5.06e-05	0.000392	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PTGS2—glaucoma	5.06e-05	0.000392	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CTSA—glaucoma	5.04e-05	0.00039	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	5.03e-05	0.000389	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	5.03e-05	0.000389	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CDKN1B—glaucoma	4.79e-05	0.000371	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CDKN1B—glaucoma	4.79e-05	0.000371	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—APOE—glaucoma	4.78e-05	0.00037	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—VEGFA—glaucoma	4.77e-05	0.000369	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CA2—glaucoma	4.76e-05	0.000368	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	4.75e-05	0.000368	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CAV1—glaucoma	4.73e-05	0.000366	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—NOS3—glaucoma	4.63e-05	0.000359	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—NOS3—glaucoma	4.63e-05	0.000359	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—GSTM1—glaucoma	4.6e-05	0.000356	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	4.54e-05	0.000351	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.44e-05	0.000344	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.38e-05	0.000339	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—TXN—glaucoma	4.35e-05	0.000337	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTGS2—glaucoma	4.24e-05	0.000328	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PTGS2—glaucoma	4.24e-05	0.000328	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GSTT1—glaucoma	4.15e-05	0.000321	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TNF—glaucoma	4.09e-05	0.000316	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.06e-05	0.000315	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.97e-05	0.000307	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.93e-05	0.000304	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NARFL—glaucoma	3.91e-05	0.000302	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CA5A—glaucoma	3.91e-05	0.000302	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CA1—glaucoma	3.88e-05	0.0003	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.8e-05	0.000294	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CTSA—glaucoma	3.75e-05	0.000291	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—NOS3—glaucoma	3.58e-05	0.000277	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.55e-05	0.000275	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CA2—glaucoma	3.55e-05	0.000275	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.5e-05	0.000271	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.47e-05	0.000268	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.47e-05	0.000268	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GSTT1—glaucoma	3.37e-05	0.000261	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—TXN—glaucoma	3.35e-05	0.00026	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ABCA1—glaucoma	3.31e-05	0.000256	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CYP1B1—glaucoma	3.31e-05	0.000256	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTGS2—glaucoma	3.27e-05	0.000253	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CA1—glaucoma	3.1e-05	0.00024	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CTSA—glaucoma	3e-05	0.000232	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.99e-05	0.000231	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CA1—glaucoma	2.92e-05	0.000226	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CA1—glaucoma	2.89e-05	0.000224	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CA2—glaucoma	2.83e-05	0.000219	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.83e-05	0.000219	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CTSA—glaucoma	2.83e-05	0.000219	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CTSA—glaucoma	2.8e-05	0.000217	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.72e-05	0.000211	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ABCA1—glaucoma	2.69e-05	0.000208	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CYP1B1—glaucoma	2.69e-05	0.000208	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CA2—glaucoma	2.67e-05	0.000207	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CA2—glaucoma	2.65e-05	0.000205	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GSTM1—glaucoma	2.64e-05	0.000205	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTT1—glaucoma	2.6e-05	0.000201	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.59e-05	0.0002	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.59e-05	0.0002	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—TXN—glaucoma	2.5e-05	0.000193	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CA1—glaucoma	2.47e-05	0.000191	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CTSA—glaucoma	2.39e-05	0.000185	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.35e-05	0.000182	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—MTHFR—glaucoma	2.34e-05	0.000181	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.28e-05	0.000176	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CA2—glaucoma	2.26e-05	0.000175	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.26e-05	0.000175	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.21e-05	0.000171	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.21e-05	0.000171	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—APOE—glaucoma	2.18e-05	0.000168	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CAV1—glaucoma	2.16e-05	0.000167	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GSTM1—glaucoma	2.15e-05	0.000166	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ABCA1—glaucoma	2.07e-05	0.00016	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYP1B1—glaucoma	2.07e-05	0.00016	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.02e-05	0.000156	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TXN—glaucoma	2e-05	0.000154	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTT1—glaucoma	1.94e-05	0.00015	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CA1—glaucoma	1.91e-05	0.000148	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—MTHFR—glaucoma	1.9e-05	0.000147	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TXN—glaucoma	1.88e-05	0.000146	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TXN—glaucoma	1.86e-05	0.000144	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CTSA—glaucoma	1.85e-05	0.000143	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.78e-05	0.000138	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—APOE—glaucoma	1.77e-05	0.000137	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CAV1—glaucoma	1.75e-05	0.000136	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CA2—glaucoma	1.74e-05	0.000135	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.7e-05	0.000132	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.69e-05	0.00013	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTM1—glaucoma	1.66e-05	0.000128	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—NOS3—glaucoma	1.63e-05	0.000126	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TXN—glaucoma	1.59e-05	0.000123	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.56e-05	0.000121	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTT1—glaucoma	1.55e-05	0.00012	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ABCA1—glaucoma	1.54e-05	0.000119	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP1B1—glaucoma	1.54e-05	0.000119	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS2—glaucoma	1.49e-05	0.000115	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MTHFR—glaucoma	1.46e-05	0.000113	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTT1—glaucoma	1.46e-05	0.000113	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.45e-05	0.000113	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTT1—glaucoma	1.45e-05	0.000112	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.44e-05	0.000111	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—APOE—glaucoma	1.36e-05	0.000105	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CAV1—glaucoma	1.35e-05	0.000105	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NOS3—glaucoma	1.32e-05	0.000103	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTT1—glaucoma	1.24e-05	9.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTM1—glaucoma	1.23e-05	9.55e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ABCA1—glaucoma	1.23e-05	9.54e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP1B1—glaucoma	1.23e-05	9.54e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TXN—glaucoma	1.23e-05	9.52e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—glaucoma	1.21e-05	9.38e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.17e-05	9.02e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ABCA1—glaucoma	1.16e-05	8.99e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP1B1—glaucoma	1.16e-05	8.99e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ABCA1—glaucoma	1.15e-05	8.92e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP1B1—glaucoma	1.15e-05	8.92e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MTHFR—glaucoma	1.09e-05	8.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NOS3—glaucoma	1.02e-05	7.9e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—APOE—glaucoma	1.02e-05	7.86e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CAV1—glaucoma	1.01e-05	7.79e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.96e-06	7.71e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTM1—glaucoma	9.86e-06	7.63e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP1B1—glaucoma	9.84e-06	7.62e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ABCA1—glaucoma	9.84e-06	7.62e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTT1—glaucoma	9.53e-06	7.38e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—glaucoma	9.34e-06	7.23e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTM1—glaucoma	9.29e-06	7.19e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTM1—glaucoma	9.21e-06	7.13e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MTHFR—glaucoma	8.71e-06	6.74e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MTHFR—glaucoma	8.21e-06	6.35e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MTHFR—glaucoma	8.14e-06	6.3e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APOE—glaucoma	8.11e-06	6.28e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CAV1—glaucoma	8.03e-06	6.22e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTM1—glaucoma	7.87e-06	6.09e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APOE—glaucoma	7.64e-06	5.92e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NOS3—glaucoma	7.61e-06	5.89e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP1B1—glaucoma	7.6e-06	5.88e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ABCA1—glaucoma	7.6e-06	5.88e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APOE—glaucoma	7.58e-06	5.86e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CAV1—glaucoma	7.57e-06	5.86e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CAV1—glaucoma	7.51e-06	5.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—glaucoma	6.96e-06	5.39e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MTHFR—glaucoma	6.95e-06	5.38e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOE—glaucoma	6.47e-06	5.01e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CAV1—glaucoma	6.41e-06	4.97e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NOS3—glaucoma	6.07e-06	4.7e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTM1—glaucoma	6.07e-06	4.7e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NOS3—glaucoma	5.72e-06	4.43e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NOS3—glaucoma	5.67e-06	4.39e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—glaucoma	5.56e-06	4.3e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MTHFR—glaucoma	5.37e-06	4.15e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—glaucoma	5.24e-06	4.05e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—glaucoma	5.19e-06	4.02e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOE—glaucoma	5e-06	3.87e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CAV1—glaucoma	4.95e-06	3.83e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NOS3—glaucoma	4.85e-06	3.75e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—glaucoma	4.44e-06	3.43e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NOS3—glaucoma	3.74e-06	2.9e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—glaucoma	3.42e-06	2.65e-05	CbGpPWpGaD
